
Sign up to save your podcasts
Or


AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
By The Motley Fool4.7
16041,604 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.

3,223 Listeners

1,500 Listeners

806 Listeners

948 Listeners

522 Listeners

1,180 Listeners

2,171 Listeners

827 Listeners

1,418 Listeners

1,039 Listeners

9,628 Listeners

192 Listeners

810 Listeners

79 Listeners

40 Listeners

985 Listeners

43 Listeners